Comprehensive testing for every type of cancer with advanced genomic analysis
Results in 24 Hours
Rapid detection and analysis with same-day results for urgent cases
97.7% Accuracy
Industry-leading precision with validated clinical-grade testing protocols
For Providers
OncoSure’s Advanced Cancer Screening Technology.
Detecting cancer can be challenging due to limited existing screening tests, long turnaround times, high costs, and invasive procedures. OncoSure's innovative technology allows for early detection, even at stage -1, and provides crucial information for guiding further imaging tests with our detailed Oncosome count.
OncoSure's advanced cancer screening technology utilizes rapid in situ hybridization and DNA fluorescent probes, offering comprehensive cancer screening with high accuracy. Our approach includes a rapid SITU Hybridization Platform, DNA Fluorescent Probes for ploidy detection, and inexpensive density gradient and low sequential centrifugation, which enable comprehensive screening for aneuploidy of all chromosomes.
Hear directly from our customers about their experience with OncoSure
About OncoSure
Our Mission is to Revolutionize Cancer Detection.
The best way to fight cancer is by catching it early. Regular screenings can significantly increase your chances of a positive outcome. Effective screenings can:
Detect cancer early, giving you the best chance for a positive outcome.
Reduce the risk of dying from cancer with regular testing.
Provide fast results, so you can act quickly.
While cancer is fundamentally linked to genetic mutations, the role of metabolic dysfunction is increasingly recognized as a significant factor in its development and progression. This dual understanding may enhance our approach to cancer treatment and prevention, suggesting that both genetic and metabolic factors should be considered in cancer research and therapy.
The ongoing exploration of cancer's metabolic aspects could lead to innovative strategies that complement traditional genetic-focused treatments.
Your doctor will help you create a screening schedule based on age, health, family history, and unique risk factors. Here are some common screenings and the individuals who should consider them:
Lung Cancer
If you're a smoker over the age of 50, it's crucial to get a lung cancer screening.
Cervical Cancer
If you’re over 21, regular screenings for cervical cancer are essential.
Breast Cancer
Women over 40 should have regular mammograms for breast cancer.
Colon Cancer
Starting at age 45, regular colonoscopies are vital for detecting colon cancer.
Beyond oncology, we offer comprehensive genetic testing services to optimize your healthcare journey. From personalized medication selection to disease risk assessment, unlock the power of your DNA for better health decisions.
Pharmacogenomics (PGx)
Optimize medication selection and dosing based on your genetic profile for safer, more effective treatment.
From pharmacogenomics to wellness panels, our genetic testing services complement our oncology expertise to provide a complete picture of your health. Discover how your DNA can guide better treatment decisions and preventive care.
This test was developed, and its performance characteristics were determined by OncoSure Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. The test was performed in a CLIA-certified laboratory and is intended for clinical purposes. OncoSure Laboratories is also COLA-accredited, having received a perfect score on its most recent inspection.
